HealthcareServices

Hypertrophic And Keloid Scar Treatment Market Outlook: Growth and Forecast Highlights 2030

February 25, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the hypertrophic and keloid scar treatment market from 2026–2035 with trusted insights from The Business Research Company

How much is the Hypertrophic And Keloid Scar Treatment Market valued at in 2026, and what valuation is forecast for 2030?

The hypertrophic and keloid scar treatment market has experienced robust growth in recent years. It is anticipated to expand from $8.49 billion in 2025 to $9.33 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.9%. The market’s past growth can be attributed to several factors including an increasing volume of surgical procedures, a rise in the incidence of trauma and burns, the extensive use of corticosteroid injections, the proliferation of dermatology and cosmetic clinics, and the undeniable aesthetic impact of scars.

The hypertrophic and keloid scar treatment market size is expected to experience substantial growth in the upcoming years, projected to reach $13.77 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 10.2%. This growth over the forecast period is attributed to an increasing inclination towards non-invasive scar treatments, the expanding adoption of laser and radiotherapy techniques, heightened awareness regarding timely scar management, the proliferation of combination treatment protocols, and enhanced accessibility to advanced dermatology services. Prominent trends for the forecast period include a greater embrace of combination scar management therapies, a rising demand for minimally invasive and non-surgical treatments, the growing application of laser and energy-based scar revision techniques, the expansion of post-surgical and preventive scar care solutions, and an intensified focus on early intervention and long-term scar control.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10692&type=smp

What Drivers Are Influencing The Growth Of The Hypertrophic And Keloid Scar Treatment Market?

The hypertrophic and keloid scar treatment market is projected to expand due to a rise in road accidents and burn incidents. Road accidents are defined as occurrences on roads involving at least one vehicle and individuals. Both road accidents and burn cases necessitate immediate care and suitable interventions for prevention and effective recovery. Hypertrophic and keloid scar treatments are utilized for individuals injured in road accidents to diminish scar height and restrictiveness. Consequently, an uptick in road accidents and burn cases contributes to the expansion of the hypertrophic and keloid scar treatment market. For example, in January 2025, The Health Foundation, a UK-based independent organization, reported that in 2023, there were 43 serious or fatal casualties per billion miles traveled by car, alongside 1,032 for cyclists and 1,914 for motorcyclists, while 92 pedestrians per million residents were killed or seriously injured. Thus, the escalating number of road accidents and burn cases is set to propel the hypertrophic and keloid scar treatment market. The hypertrophic and keloid scar treatment market is anticipated to grow due to the increasing number of aesthetic procedures. Aesthetic procedures are defined as non-invasive or minimally invasive cosmetic treatments carried out to enhance an individual’s appearance and address specific cosmetic concerns. Hypertrophic and keloid scar treatments are utilized in aesthetic procedures to reduce and improve the look of raised scars, contributing to a smoother, more appealing result. For instance, in June 2024, The International Society of Aesthetic Plastic Surgery (ISAPS), a US-based organization for plastic surgeons, reported that in 2023, liposuction remained the most common surgical procedure, with over 2.2 million procedures performed, maintaining its leading position from 2022. Breast augmentation and eyelid surgery followed closely, showing significant increases. Eyelid surgery notably rose by 24% to exceed 1.7 million procedures, while rhinoplasty saw a 21.6% increase, reaching a total of 1.1 million procedures compared to the prior year. Therefore, the expansion of aesthetic procedures is a key driver for the hypertrophic and keloid scar treatment market.

How Is The Hypertrophic And Keloid Scar Treatment Market Organized Into Various Segments?

The hypertrophic and keloid scar treatment market covered in this report is segmented –

1) By Treatment: Cryotherapy, Surgical Excision, Pressure Dressings, Intralesional 5-Fluorouracil, Superficial X-Ray, Intralesional Corticosteroid Injection, Other Treatments

2) By Products: Topical Products, Laser Products, Injectables, Other Products

3) By Scar: Hypertrophic Scars, Keloid Scars

4) By End-Use: Hospitals, Clinics, Other End-Users

Subsegments:

1) By Cryotherapy: Liquid Nitrogen Cryotherapy, Intralesional Cryotherapy

2) By Surgical Excision: Simple Excision, Excision With Skin Grafting

3) By Pressure Dressings: Elastic Bandage Pressure Dressings, Silicone Gel Pressure Dressings

4) By Intralesional 5-Fluorouracil: Standalone 5-FU Treatment, Combination With Corticosteroids

5) By Superficial X-Ray: Low-Dose X-Ray Therapy, Combination X-Ray With Other Treatments

6) By Intralesional Corticosteroid Injection: Triamcinolone Acetonide Injection, Combination With 5-Fluorouracil

7) By Other Treatments: Laser Therapy, Radiotherapy, Interferon Therapy

Which Innovation Trends Are Advancing Developments Within The Hypertrophic And Keloid Scar Treatment Market?

Leading companies within the hypertrophic and keloid scar treatment market are concentrating on developing clinically validated silicon-based products, such as medical-grade silicone strips, to maximize their earnings. These medical-grade silicone strips are therapeutic items produced from high-quality silicone, specifically designed to aid in scar healing and reduction. For example, in April 2023, Scar Erase, a UK-based firm offering silicone-based scar reduction therapy, introduced its Scar Erase silicone strips, which are a clinically tested and budget-friendly option for scar recovery. Formulated with 3mm of medical-grade silicone, these strips are beneficial for treating various scar categories, including hypertrophic, keloid, post-surgery, and stretch marks. This particular silicone technology envelops the scar site, encouraging hydration and an optimal healing atmosphere, thereby leading to substantial improvements in scar texture, color, and height. The product is crafted for both comfort and discreet application, offering an accessible solution for at-home scar treatment.

Who Are The Major Companies Operating In The Hypertrophic And Keloid Scar Treatment Market?

Major companies operating in the hypertrophic and keloid scar treatment market are Smith & Nephew plc, Merz Pharmaceutical LLC, Lumenis Ltd., Enaltus LLC, Sonoma Pharmaceuticals Inc., Molnlycke Health Care AB, Suneva Medical Inc., Pacific World Corporation, Perrigo Company plc, Cynosure Inc., Alliance Pharma plc, Newmedical Technology Inc., HRA Pharma, Scar Heal Inc., McKesson Medical Surgical Inc., Johnson & Johnson Private Limited, Medtronic plc, 3M Company, Sinclair Pharma plc, Avita Medical, Stratpharma AG, Biodermis, Mederma, Silagen

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/hypertrophic-and-keloid-scar-treatment-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Hypertrophic And Keloid Scar Treatment Market?

North America was the largest region in the hypertrophic and keloid scar treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global hypertrophic and keloid scar treatment market report during the forecast period. The regions covered in the hypertrophic and keloid scar treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Hypertrophic And Keloid Scar Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10692&type=smp

Browse Through More Reports Similar to the Global Hypertrophic And Keloid Scar Treatment Market 2026, By The Business Research Company

Neurotrophic Keratitis Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurotrophic-keratitis-treatment-global-market-report

Scar Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/scar-treatment-global-market-report

Keloids Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/keloids-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795